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Objective: Focal adhesion kinase is implicated in the regulation of cell adhesion, migration, survival, and cell-cycle progression. However,
the functions of focal adhesion kinase in endothelial cell (EC) in vivo remain unclear. This study aims to examine the role of FAK in EC
function and angiogenesis in vivo by transgenic mice approach.
Method: We generated transgenic mice which overexpressed chicken FAK in vascular endothelial cell under the control of the Tie-2
promoter and enhancer. FAK transgene was detected by RT-PCR, immunoprecipitation, and Western blot. The effect of FAK overexpression
on angiogenesis was determined using skin wound healing and ischemia skeleton muscle models.
Results: Expression of FAK transgene was detected in all vessel-rich tissues. Expression of FAK protein was verified by antibody specific for
the exogenous chicken FAK in lung homogenates and isolated EC. In the wound-induced angiogenesis model, the number of vessels in the
granulation tissue of healing wound was significantly increased in the transgenic mouse compared to that of wild-type control mice.
Similarly, in the ischemia skeleton muscle model, the density of capillaries was significantly increased in the transgenic mouse.
Conclusion: These results indicate that FAK may play an important role in the promotion of angiogenesis in vivo.
D 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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Angiogenesis is fundamental to embryonic development
and organogenesis, as well as to the pathogenesis of many
diseases including coronary heart disease, cancer and0008-6363/$ - see front matter D 2004 European Society of Cardiology. Publishe
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E-mail address: jg19@cornell.edu (J.-L. Guan).inflammation [1]. Vascular endothelial cells (ECs) play a
pivotal role in angiogenesis, functioning as transducers
and effectors of local environmental signals for vessel
formation [2]. EC sprouting is the initial step in angio-
genesis and requires cell migration into the extracellular
matrix (ECM) beneath the basement membrane [3].
Recent studies indicate that angiogenesis is regulated by
signals derived from growth factor receptors and integrins
[4,5]. Focal adhesion kinase (FAK) is a cytoplasmic
tyrosine kinase that plays a key role in integrin-mediated
signal transduction pathways [6–8]. Upon activation by
integrin-mediated cell adhesion, FAK associates with a
number of SH2 domain-containing signaling molecules,
including Src family kinases [9–12], p85 subunit of64 (2004) 421–430d by Elsevier B.V. All rights reserved.
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[14] and Grb7 [15]. Interactions of FAK with these
signaling molecules trigger a number of downstream
signaling pathways that regulate cellular functions includ-
ing spreading, migration [16–19], survival [20–24] and
cell cycle progression [18,25–27]. In addition to its well-
established role in mediating integrin signaling, FAK may
participate in growth factor receptor-induced signal trans-
duction. Recent studies suggest that FAK associates with
epidermal growth factor (EGF) and platelet-derived growth
factor (PDGF) receptors through its N-terminal domain
[28]. Thus, FAK may function as a point of convergence
in signaling pathways triggered by integrins and growth
factor receptors, both of which are important in regulating
various angiogenesis-related cellular functions.
Several studies suggest that FAK is important for
angiogenesis. FAK knockout mice die in utero at
embryonic day 8.5 with extensive defects in generation
(vasculogenesis) and subsequent growth (angiogenesis) of
vasculature [29]. Increased EC migration into a wounded
monolayer correlated with increased tyrosine phosphoryla-
tion and kinase activity of FAK [30]. Activation of
vascular endothelial growth factor (VEGF) receptor-2 by
VEGF-A induced the association of FAK with PI3K,
which mediates porcine aortic ECs migration [31].
Angiopoietin-1, another stimulator of angiogenesis, also
increased FAK phosphorylation during angiogenesis in
vitro [32]. Interestingly, a recent report showed that the
Src-dependent formation of a signaling complex of FAK
and integrin avh5 was essential for VEGF-stimulated
angiogenesis in mice in vivo [33].
Although there is abundant in vitro data suggesting an
important role for FAK in angiogenesis, little is known
about the in vivo function of FAK in ECs during angio-
genesis. To investigate the physiological role of FAK for
vascular development and angiogenesis in vivo, we estab-
lished transgenic mice that overexpress FAK specifically in
vascular ECs, using the Tie2 promoter and enhancer. This
was the first well-characterized, EC-specific promoter that
drives target gene expression throughout embryogenesis and
adulthood in ECs [34,35]. Our results show that over-
expression of FAK in ECs can promote angiogenesis during
wound healing and in response to ischemia.2. Materials and methods
2.1. Generation and identification of transgenic mice
Transgenic mice were generated using pSPTg.T2FpAXK
(pg52) plasmid (kindly provided by Dr. Thomas Sato,
University of Texas Southwestern Medical Center), which
contains the Tie2 promoter and enhancer and a SV40 PolyA
signal (personal communication). A 3.2-kb full-length
chicken FAK cDNA was excised with PvuI and HincII
from pBS-FAK [36]. A NotI linker was ligated to HincII siteof this fragment and the resulting product was then
subcloned into pg52 at the NotI site. The Tie2-FAK
transgene was then excised with SalI from the vector
backbone for injection. Gel-purified Tie2-FAK transgene
was microinjected into pronuclei of fertilized mouse eggs
from C57BL/6 X CBA/J mice, which were then transferred
into pseudopregnant female mice. All study protocols were
approved by the Institutional Animal Care and Use
Committee of Cornell University and conform to the Guide
for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No.
85-23, revised 1996).
Potential founder mouse strains and their offspring were
identified by PCR and Southern blot analysis with genomic
DNA prepared from tail biopsies. Routine genotyping was
performed by PCR with the use of a forward primer
corresponding to the Tie2 promoter (5V-GGGAAGTCG-
CAAAGTTGTGAGTT-3V) and a reverse primer correspond-
ing to the FAK cDNA (5V-CTCCATGCCGGATAATGC-3V)
to amplify a 300-bp fragment spanning the junction between
the Tie2 promoter and FAK cDNA. The PCR conditions
were as follows: 1 cycle at 94 8C for 10 min, 35 cycles at 94
8C for 1 min, 55 8C for 1 min and 72 8C for 1 min, 1 cycle at
72 8C for 10 min. Southern blot analysis was performed
with HindIII-digested mouse tail genomic DNA using the
PCR product as a probe.
2.2. Reverse transcription–polymerase chain reaction
(RT–PCR) analysis
Total RNA was isolated from mouse lung, heart, liver,
spleen, kidney and brain with TRIZOL (Invitrogen, CA) and
purified with RNAeasy (Qiagen, CA) kit according to the
manufacturer’s instructions. The isolated total RNA was
digested with DNase at room temperature for 10 min to
remove potential DNA contamination. The samples were
then reverse transcribed to cDNA, amplified by PCR, and
resolved on an agarose gel. The PCR primers and conditions
were the same as described above for genotyping. Glyser-
aldehyde-3-phosphate dehydrogenase (GAPDH) was used
as reverse transcription control (primers: 5V-ACGACC-
CCTTCATTGACCTC-3V and 5V-CTTTCCAGAGGGGC-
CATCCAC-3V).
2.3. Isolation of ECs from transgenic mice
Primary ECs were isolated by positive selection using
immunobead precipitation from the lungs of 6–12-week-old
mice as previously described [37]. Briefly, lungs were
harvested, minced, then digested with Type I collagenase (2
mg/ml, Worthington Biomedical, Lakewood, NJ) at 37 8C
for 45 min. The digested tissue was mechanically disso-
ciated using vigorous flushing through a metal cannula,
passed through a 70-Am filter (Becton Dickinson Labware,
Becton, MA), then centrifuged at 400g for 8 min at 4 8C.
The cells were re-suspended in cold Dulbecco’s phosphate-
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murine CD31 (PECAM-1, clone MEC 13.3, BD Bioscien-
ces, San Jose, CA)-coated magnetic beads (M-450, sheep
anti-rat IgG Dynabeads, Dynal, Great Neck, NY) at 15 Al/ml
for 10 min at room temperature. The beads were washed
several times in cold isolation medium (high glucose
Dulbecco’s modified Eagle’s medium containing 20% fetal
bovine serum, penicillin, streptomycin (at standard concen-
trations) and 0.02 M HEPES), re-suspended in growth
medium (isolation medium supplemented with heparin (100
Ag/ml), endothelial cell mitogen (100 Ag/ml, Biomedical
Technologies, Stoughton, MA), l-glutamine, non-essential
amino acids and sodium pyruvate at standard concentra-
tions), and cultured in 0.1% gelatin (Sigma)-coated 100 mm
tissue culture dishes at 37 8C in 5% CO2. When the cells
reached 80–90% confluence, they were detached using
trypsin–ethylenediaminetetraacetic acid (EDTA). The cells
were then centrifuged in isolation medium, re-suspended in
DPBS then incubated with rat anti-murine CD102 (ICAM-2,
BD Biosciences)-coated Dynabeads for 10 min at room
temperature. After washing in isolation medium, the beads
were re-suspended in growth medium and cultured in 100
mm culture dishes at 37 8C in 5% CO2. Confluent cells were
used at passages 1–3.
2.4. Flow cytometry
Confluent cultures were detached using trypsin–EDTA,
centrifuged and the cell pellet was re-suspended in PBS
containing 1% bovine serum albumin (BSA). The cells were
then incubated with fluoroscein isothiocyanate (FITC)-
conjugated rat anti-murine CD102 and phycoerythrin
(PE)-conjugated rat anti-murine CD31, with appropriate
isotype controls (BD Biosciences), on ice for 30 min. After
washing twice in PBS/1% BSA, the cells were fixed in 1%
paraformaldehyde in PBS. Analysis was performed using a
FACScaliber (BD Biosciences). Cells were gated on forward
and side scatter characteristics (linear scales). After applying
appropriate compensation settings using isotype controls,
10,000 gated cells were counted and analyzed for positive
fluorescence (log scale). The percentage of cells positive for
FITC-CD102 and PE-CD31 was determined from dotplots,
using the quadrant tool on the FACScaliber.
2.5. Immunoprecipitation and Western blot
The rabbit anti-FAK serum (a-KC) that recognizes FAK
from different species has been described previously [9]. A
new rabbit antiserum specific for chicken FAK (anti-cFAK)
was prepared by Proteintech (Chicago, IL) using a synthetic
peptide corresponding to chicken FAK amino acid 781–796
(see Fig. 3A). Anti-cFAK antibody was conjugated to
protein A beads according to the manufacturer’s instruc-
tions. Briefly, 0.5 ml antiserum was mixed with 2 ml protein
A beads in 6 ml PBS and incubated at 4 8C overnight.
Protein A beads were then transferred to a column andwashed with PBS and borate buffer (0.2 M sodium borate,
pH 9.0). The protein A beads were then incubated with 20
mM dimethyl pimelimidate (Pierce Biotechnology, IL) at
room temperature for 1 h. They were then washed two times
with 0.2 M ethanolamine (pH 8.0) and PBS.
For most experiments, subconfluent cells or tissues
isolated from mice were washed three times with ice-cold
PBS and then lysed with modified RIPA buffer (50 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM sodium vanadate, 10 mM sodium
pyrophosphate, 10 mM NaF, 1% Triton X-100, 0.5% SDS,
0.1% EDTA, 10 Ag/ml leupepetin, 10 Ag/ml aprotinin and 1
mM PMSF). Lysates were cleared by centrifugation and
total protein concentrations were determined using the Bio-
Rad Protein Assay (Hercules, CA). Immunoprecipitation
was carried out by incubating lysates with anti-cFAK
conjugated-protein A beads at 4 8C for overnight. The
beads were then washed twice using RIPA buffer and once
with PBS. After washing, the beads were boiled with
loading buffer and resolved by SDS–PAGE. Western
blotting was performed using a-KC (1:1000) as the primary
antibody and horseradish peroxidase (HRP)-conjugated goat
anti-rabbit IgG (1:5000) as the secondary antibody. A
chemoluminescent substrate (Amersham ECL) was used to
detect the signal.
In some experiments, lysates from isolated ECs were
analyzed directly by antibodies against FAK (C-20, Santa
Cruz), Y397 phosphorylated FAK (Upstate) or vinculin
(Sigma) at 1:1000 dilutions.
2.6. Wound healing assay
Mice were anesthetized with sodium pentobarbital (160
mg/kg) intraperitoneally for the surgical procedure, which
was performed under aseptic conditions. Four full-thickness
wounds were made on the backs of 12-week-old mice using a
2-mm skin punch. Seven days later, micewere euthanized and
wounds were excised and fixed in 10% buffered formalin and
stored for histology and immunohistochemistry (see below).
2.7. Hindlimb ischemia model
To create unilateral hindlimb ischemia, the femoral artery
of 6-month-old mice was exposed by incising the skin
overlying the medial femor, as described previously [38].
The femoral artery and vein were ligated proximally and all
side-branches were dissected free. The overlying skin was
then closed using surgical silk. Four weeks later, mice were
euthanized and three biopsies of ischemic tissue were saved
and fixed in 10% (w/v) buffered formaldehyde for histology
and immunohistochemistry examination (see below).
2.8. Histology and immunohistochemistry
After euthanasia, complete postmortem examination
was performed and tissue samples were collected. Tissue
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formaldehyde for overnight. Representative samples were
then progressively dehydrated in ethanol, cleared with
xylene and embedded in paraffin wax according to
standard laboratory procedures. Sections of 4 Am were
stained with hematoxylin and eosin (HE) for routine
histopathological examination with light microscopy. Par-
affin-embedded 4-Am sections of biopsied tissues were
deparaffinized with xylene, rehydrated in 100%, 95% and
75% ethanol baths, and then treated with 3% hydrogen
peroxide in methanol to quench endogenous peroxidase
activity. After blocking with 10% goat serum, samples
were incubated with affinity purified polyclonal rabbit anti-
CD31 (1:200) as primary antibody. After washing in PBS,
the samples were incubated with biotinylated goat anti-
rabbit IgG followed by streptavidin–HRP (ImmunoCruz
Staining System, Santa Cruz, CA), using DAB as a
substrate. The number of capillaries was counted in 10
random high (40) magnification fields by a double-
blinded veterinary pathologist.
2.9. Statistical analyses
Data are presented as meanFstandard deviation. Means
were compared by analysis of variance between groups
(ANOVA). PV0.05 was considered statistically significant.Fig. 1. Generation of Tie2-FAK transgenic mice. (A) Schematic representation of th
promoter and enhancer cassette. The location of the primers (arrows) used in the P
(H) used in digestion for Southern blotting are shown below and above, respective
and resolved on an 1% agarose gel, with DNA molecular weight markers, as indica
the left. (C) DNA from tails of transgenic and WT mice were digested by HindI
product as a probe. The expected 1.7-kb band for FAK transgene is marked by a3. Results
3.1. Generation of Tie2-FAK transgenic mice
To investigate the potential function of FAK in angio-
genesis in vivo, we created transgenic mice that express
FAK in vascular ECs under the control of the Tie2 promoter
and enhancer. Tie2 is a vascular EC-specific receptor
tyrosine kinase that plays an important role in the regulation
of vascular network formation and remodeling. The Tie2
promoter and enhancer cassette has been well characterized
and used for specific expression of exogenous genes in EC
of the entire vasculature in vivo [34,35]. The cDNA
encoding full-length chicken FAK was subcloned into the
vector between the Tie2 promoter and enhancer (Fig. 1A),
and used for generation of transgenic mice as described in
the Materials and Methods. Two stable independent trans-
genic mouse lines (TG-19 and TG-34) were obtained and
used for experiments.
The Tie2-FAK transgene was detected by PCR using
oligonucleotides corresponding to the Tie2 promoter and
FAK, as forward and reverse primers, respectively. As
expected, this combination of primers amplified a band of
300 bp from the transgenic mice, but not the endogenous
Tie2 or FAK gene of the transgenic or wild type (WT)
mouse (Fig 1B). We also confirmed the presence of thee FAK construct used to generate transgenic mice under control of the TIE2
CR and the expected 300-bp PCR product and the restriction sites HindIII
ly. (B) DNA from tails of transgenic and WT mice were amplified by PCR
ted. The expected 300-bp band for FAK transgene is marked by an arrow on
II and then subjected to Southern blotting analysis using the 300 bp PCR
n arrow on the right.
Fig. 3. Expression of transgenic FAK in vascular ECs. (A) Alignment of
chicken FAK sequence with the corresponding sequence of murine FAK.
(B) Cell lysates were prepared from FAK cells under non-induced and
induced conditions, lungs of WT and transgenic mice, and isolated ECs of
WT and transgenic mice, as indicated. Lysates were immunoprecipitated by
anti-cFAK antiserum and blotted for FAK with a-KC. (C) FACS analysis of
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PCR product as a probe (Fig. 1C). The Tie2-FAK transgenic
mice were indistinguishable from WT mice and they did not
display any detectable developmental abnormalities. No
macroscopic or microscopic lesions were found that could
be attributable to the presence of the transgene. Normal
mendelian inheritance of the transgene was observed when
hemizygous mice were intercrossed. Together, these results
suggested that overexpression of FAK in vascular ECs does
not affect mice development.
3.2. Analysis of FAK transgene expression in the ECs
To evaluate expression of the transgene, we first
examined mRNA expression levels of the transgene by
RT–PCR using total RNA isolated from mouse lungs which
are highly vascularized and contain abundant ECs. Oligo-
nucleotides corresponding to the Tie2 promoter and FAK
were used as the primer pair specific for the transgene, but
will not amplify endogenous Tie2 or FAK mRNA (see Fig.
1B). We detected the FAK transgene RNA from transgenic,
but not from WT mice. RNA of GAPDH (450 bp), a
housekeeping gene, was detected in both RNA samples
(Fig. 2A). Furthermore, bands were not detected when the
reverse transcription step was eliminated, indicating that the
signals were not due to DNA contamination of the RNA
samples (Fig. 2A, odd number lanes). We next examined
transgene expression in other tissues with abundant ECs,
using similar methods. The FAK transgene RNA was
expressed in all tissues examined, including the heart, liver,
spleen, kidney and brain (Fig. 2B). These results are
consistent with a previous report showing that the Tie2       
Fig. 2. Detection of FAK transgene by RT–PCR. Total RNA was isolated
from lungs of transgenic and WT mice (A) or various tissues of transgenic
mice (B), as indicated. RNA samples were analyzed with (even number
lanes) or without (odd number lanes) the reverse transcription step prior to
PCR. The expected 300-bp band for FAK transgene and the 450-bp band
for GAPDH control are marked by arrows on the left.
lung ECs from WT and transgenic mice, as indicated. Greater than 80% of
cells are ECs, as shown by double positive staining for CD31-PE and
CD102-FITC (upper right quadrant). (D) Lysates from lung ECs were
analyzed by Western blotting using antibodies against FAK (top panel),
PY397 of FAK (middle panel), or vinculin (bottom panel), as indicated. The
relative expression of FAK (normalized to vinculin expression and then to
FAK in WT mice) were obtained from three independent experiments
(average and S.D.) and shown on the right.promoter and enhancer directs gene expression in ECs of the
entire vasculature [34,35].
FAK is highly conserved among the species. We tested
various available FAK antibodies, but none could distin-
guish chicken and mouse FAK. Therefore, to demonstrate
expression of the exogenous chicken FAK protein in the
transgenic mice, we prepared an antiserum using a synthetic
peptide corresponding to residues 781–796 in chicken FAK.
This is the most divergent region from the mouse FAK
sequence (Fig. 3A). The specificity of this antiserum (anti-
cFAK) was tested using NIH3T3 cell clone with tetracy-
cline-inducible expression of exogenous chicken FAK
(designated FAK cells) [26]. The anti-cFAK specifically
immunoprecipitated chicken FAK from FAK cells under
induced conditions but not the endogenous mouse FAK in
the uninduced cells, as shown by Western blotting analysis
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3B; lanes 1 and 2). We then examined exogenous chicken
FAK expression in the lungs from the transgenic and WT
mice. The exogenous chicken FAK was detected in the anti-
cFAK immunoprecipitates of lysates from transgenic mice,
but not from WT mice (lanes 3 and 4), confirming that the
transgene is expressed at the protein level.
To confirm that the FAK transgene was expressed in
ECs, we also isolated ECs from the lungs of transgenic and
WT mice using magnetic bead immunoisolation, as
described in the Materials and Methods. After two rounds
of positive selection with beads coated with anti-murine
CD31 and anti-murine CD102, we routinely obtained a
yield of 80% ECs, as determined by the percentage of cells
double positive for CD31 and CD102 by flow cytometry
(Fig. 3C). The identity of ECs was further verified by their
cobblestone morphology and immunofluorescent staining
with anti-VE-cadherin (data not shown). Immunoprecipita-
tion assays using the purified ECs confirmed exogenous
FAK expression in the transgenic mice (Fig. 3B, lanes 5 and
6). Analysis of the lysates by an antibody that recognizes
both transfected chicken FAK and endogenous mouse FAK
shows an approximately 50% increase in the total FAKFig. 4. Overexpression of FAK increases capillary density in wound healing. (A) F
the back of 3-month-old mice (n=4). One week later, the capillary density was m
(bottom two panels). Sections of normal skin were also stained with anti-CD31 (top
the number of vessels per field for 10 fields and expressed as meanFS.D. vessel nuexpression for both transgenic strains, suggesting that the
transgene is expressed at about 50% level as the endogenous
mouse FAK (Fig. 3D). Furthermore, total FAK that are
phosphorylated at Y397 is also increased by about 50%,
suggesting that the chicken FAK transgene was regulated in
a similar manner as the endogenous mouse FAK. Together,
these results demonstrate expression of FAK in ECs of
transgenic mice under the control of the Tie2 promoter.
3.3. Enhancement of wound-induced angiogenesis by FAK
overexpression
Previous in vitro studies have suggested potential roles
for FAK in EC migration and angiogenesis [30,39]. To
investigate this possibility in vivo, we examined wound-
induced angiogenesis in the transgenic mice and WT mice.
The rate of wound healing of back incision wounds was
similar between the transgenic and WT mice. Histological
examination by staining with H/E did not show any
apparent differences in the healing wounds. To quantify
angiogenesis in the granulation tissue, vascular density was
evaluated by CD31 staining of ECs 7 days after wounding.
CD31 staining was increased in granulation tissue ofour excision full-thickness wounds were made with a skin biopsy punch on
easured with immunohistochemistry using polyclonal anti-CD31 antibody
two panels) (bar=50 Am). (B) Capillary density was quantified by counting
mber per field (*vs. control, pb0.05; #vs. respective normal skins, pb0.05).
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of vessels per field were significantly (Pb0.05) increased
(by about 80%) in wound of transgenic, compared with WT
mice (Fig. 4B). In normal skin, we did not observe any
difference in the number of vessels between WT and
transgenic mice. These results suggested that overexpres-
sion of FAK in the ECs of transgenic mice may promote
angiogenesis in response to wounding.
3.4. FAK overexpression increase capillary density in
hindlimb ischemia
We also examined the effects of FAK overexpression on
angiogenesis using the hindlimb ischemia model [38]. The
left femoral artery and vein were ligated to induce
unilateral hindlimb ischemia in transgenic and WT mice.
All mice survived after surgery and appeared healthy
during the following 4 weeks. The ischemic femoral
muscles were then harvested and examined for capillary
density by immunohistochemistry, using CD31 as an EC
marker to determine the extent of angiogenesis. VesselFig. 5. Overexpression of FAK increases capillary density in ischemic hindlimb m
(n=6) mice was ligated. Four weeks later, capillary density of the ischemic musc
CD31 (bottom two panels). Sections of normal muscle were also stained with anti-C
counting the number of vessels per field across at least 10 random fields and exp
respective normal muscles, pb0.05).density was significantly increased in femoral muscles
from transgenic compared to WT mice (Fig. 5A).
Quantitative analysis revealed a statistically significant
increase of about 120% (Pb0.05) in the density of
capillaries of transgenic mice compared to WT mice
(Fig. 5B). In normal muscle, we did not observe any
difference in the number of vessels between WT and
transgenic mice. Together with the data from the wound-
induced angiogenesis model, these results strongly suggest
that FAK stimulates angiogenesis in vivo.4. Discussion
Angiogenesis and neovascularization are complex pro-
cesses controlled by signals derived from receptors for
ECM proteins and growth factors. Consistent with its role
in mediating signal transduction by integrins and growth
factor receptors, recent studies have shown that FAK is
important for EC migration and angiogenesis in vitro
[32,39]. However, direct demonstration of FAK’s role inuscle. (A) The left femoral artery of 6-month-old transgenic (n=9) and WT
le biopsies was evaluated by immunohistochemistry using polyclonal anti-
D31 (top two panels) (bar=50 Am). (B) Capillary density was quantified by
ressed as meanFS.D. vessel numbers per field (*vs. control, pb0.05; #vs.
X. Peng et al. / Cardiovascular Research 64 (2004) 421–430428angiogenesis remains to be established in vivo. In this
study, we generated a new transgenic mice line that
targeted overexpression of FAK to vascular ECs using
the Tie2 promoter. We showed that the FAK transgene is
expressed in all vessel-rich tissues examined and in
isolated ECs from the lungs. Although they developed
normally, transgenic mice exhibited increased angiogenesis
in the wound healing and ischemic hindlimb angiogenesis
assays. These results provide direct support for a role of
FAK in angiogenesis in vivo.
Dynamic interactions between ECs and ECM are
essential for angiogenesis [4]. This interaction is mediated
mainly by integrins, which are composed of a large family
of non-covalently linked a and h heterodimers [40,41].
Currently, 11 members of the family (a1–7h1, avh1, avh3,
avh5 and a6h4) are known to be expressed in ECs at various
times, and most have been suggested to be involved in the
regulation of angiogenesis [42]. For example, VEGF-
induced angiogenesis was inhibited by antibodies against
a1h1 and a2h1 [43]. h1-knockout mice die in utero at E5.5
before the vascular system forms, preventing assessment of
its role in angiogenesis. However, the differentiation of ECs
derived from h1/ embryoid bodies is delayed [44,45]. In
a5-knockout mice, the formation of extraembryonic and
embryonic vessels was severely impaired [46]. These
studies strongly suggest a potential role of FAK in angio-
genesis because it is a major mediator of integrin signaling.
FAK may also participate in growth factor receptor signal-
ing. A recent study has shown that FAK is required for
angiogenesis induced by VEGF and basic fibroblast growth
factor (bFGF) in vitro [33]. Taken together with data shown
here, FAK may function as one of converging points in the
signaling pathway triggered by integrins and growth
factor receptors, that are important in the regulation of
angiogenesis.
Deletion of the FAK gene in mice results in embryonic
lethality with major defects in embryonic vasculogenesis
and angiogenesis [17,29]. Interestingly, overexpression of
FAK in ECs did not affect these processes during embryonic
development, although we cannot exclude subtle differences
between transgenic and WT embryos. Overexpression of
FAK may promote pathophysiological angiogenesis, as
shown here in the wound healing and ischemic hindlimb
models, despite minimized effect on embryonic vasculo-
genesis and angiogenesis under physiological conditions. It
is interesting to note that hypoxia is a strong inducer of
angiogenesis by stimulating VEGF [47]. Hypoxia occurs in
wound healing and ischemia may affect VEGF levels,
although we did not evaluate these here. Hypoxia-induced
angiogenesis in these models may be further enhanced by
overexpression of FAK in ECs, because FAK is important in
VEGF-induced signaling [48–51].
Consistent with a lack of effect of overexpression of FAK
on embryonic development, we also noted that the capillary
numbers in normal skin and skeleton muscle are not
changed in transgenic mice compared with their WTlittermates (Figs. 4 and 5). This indicates that FAK is not
a limiting factor for blood vessel development under normal
conditions. However, it may become a limiting factor to
mitogenic and/or migratory responses in ECs under an
increased angiogenesis conditions in skin wound healing
and muscle ischemia. Thus overexpression of FAK could
overcome the limitation and allow enhanced angiogenesis in
transgenic mice. These considerations are based on that the
transgene chicken FAK is regulated and functions in a
similar manner as the endogenous mouse FAK. This is
highly likely given the extremely conserved sequences of
FAK among different species [52]. Indeed, we found that
the ectopic chicken FAK was phosphorylated on PY397 as
efficiently as the endogenous FAK, which caused a
corresponding increase in the total Y397 phosphorylated
FAK as the increase in total FAK protein (see Fig. 3D).
Because autophosphorylation of FAK at Y397 is critical for
both FAK regulation and function, these data suggest that
the overexpressed chicken FAK behaviored in a similar
manner as the endogenous FAK.
The mechanisms by which FAK overexpression in ECs
promotes angiogenesis in adult mice remain to be estab-
lished. It is likely, however, that FAK’s ability to promote
EC migration contributes to it [18]. EC migration is one of
the first steps of angiogenesis. Increased EC migration
correlated with increased FAK phosphorylation and activity
[30]. FAK signaling pathways also regulate cell survival and
cell cycle progression [26,52,53]. These may also contribute
to angiogenesis by FAK in vivo. Future studies will be
necessary to clarify these potential mechanisms and to
delineate FAK downstream pathways involved in its
regulation of angiogenesis in vivo.
The availability of the FAK transgenic mice model
described here will likely to be valuable tools in both
basic and clinical researches. It will provide a useful
model to further understanding the role of FAK and its
downstream signaling pathways in angiogenesis in vivo
by analysis of various FAK mutants in a similar manner.
Furthermore, crossing the FAK transgenic mice with
different integrin and/or FAK EC conditional KO mice
in the future will facilitate the analysis of integrin-FAK
signal transduction pathways in angiogenesis. Lastly, both
anti- and pro-angiogenic therapy are currently one of the
most active research areas for treatment of various
diseases such as cancer and coronary heart disease.
Elucidating the precise molecular mechanism of angio-
genesis including the role of FAK in vivo will likely
contribute to the development of potentially novel strategy
in angiogenesis based therapies.Acknowledgements
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